1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. California >
  6. Apollo Endosurgery Acquires Allergan - Obesity Intervention Division

M&A Deal Summary

Apollo Endosurgery Acquires Allergan - Obesity Intervention Division

On December 2, 2013, Apollo Endosurgery acquired medical products company Allergan - Obesity Intervention Division from Allergan for 110M USD

Acquisition Highlights
  • This is Apollo Endosurgery’s 1st transaction in the Medical Products sector.
  • This is Apollo Endosurgery’s 2nd largest (disclosed) transaction.
  • This is Apollo Endosurgery’s 2nd transaction in the United States.
  • This is Apollo Endosurgery’s 1st transaction in California.

M&A Deal Summary
Date 2013-12-02
Target Allergan - Obesity Intervention Division
Sector Medical Products
Buyer(s) Apollo Endosurgery
Sellers(s) Allergan
Deal Type Divestiture
Deal Value 110M USD

Target

Allergan - Obesity Intervention Division

Irvine, California, United States
Allergan, Inc. - Obesity Intervention Division is a manufacturer and sells weight loss solutions comprised of the LAP-BAND® adjustable gastric banding system and the ORBERA™ intra-gastric balloon system.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Apollo Endosurgery

Austin, Texas, United States
Category Company
Founded 2005
Sector Medical Products
DESCRIPTION

Apollo Endosurgery, Inc. (old) is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 500 million people globally, as well as other gastrointestinal disorders.

DEAL STATS #
Overall 2 of 2
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 2 of 2
State: California M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2013 M&A 2 of 2
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-29 Lap-Band System

United States

The lap-band procedure, which involves inserting a band around a portion of the stomach to reduce its capacity and restrict the amount of food a patient can consume.

Buy $110M

Seller(S) 1

SELLER

Allergan

Irvine, California, United States
Category Company
Founded 1948
Sector Life Science
Employees11,400
DESCRIPTION

Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.

DEAL STATS #
Overall 2 of 3
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 2 of 3
State: California M&A 1 of 2
Country: United States M&A 2 of 3
Year: 2013 M&A 2 of 2
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-29 Lap-Band System

United States

The lap-band procedure, which involves inserting a band around a portion of the stomach to reduce its capacity and restrict the amount of food a patient can consume.

Sell $110M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-27 Allergan Generics

California, United States

Allergan Generics is the generic drugs unit of Allergen Inc.

Sell $40.5B
Mergr

Solution for

Product

Company

Legal